Abstract:Objective To investigate the application value of susceptibility weighted imaging (SWI) combined with platelet distribution width (PDW) in intravenous thrombolysis for treatment of patients with acute cerebral infarction (ACI). Methods One hundred and ten patients with ACI treated by intravenous thrombolysis admitted to the Department of Radiology of the Second Affiliated Hospital of Medical College of Zhejiang University from February 2017 to June 2018 were enrolled as the subjects. Before treatment, all patients were detected by routine magnetic resonance imaging (MRI), SWI scanning and PDW detection. The patients were divided into hemorrhage group (77 cases) and non-hemorrhage group (33 cases) according to the presence or absence of hemorrhage shown in SWI, and according to the amount of bleeding, the hemorrhage group patients were subdivided into light (24 cases), medium (32 cases) and severe (21 cases) three groups. After intravenous thrombolysis, the patients were scanned by SWI to show whether bleeding being present or not, the cerebral microbleeding (CMBs) after 24 hours treatment in two groups, and after treatment of 14 days, modified Rankin score (MRS), PDW and hemorrhagic transformation (HT) situation in the two groups were evaluated and compared, the differences in hemorrhagic infarction 1 (HI1), hemorrhagic infarction 2 (HI2), parenchymal hemorrhage 1 (PH1) and parenchymal hemorrhage 2 (PH2) in different bleeding volume groups were compared. Results Before treatment, 129 lesions detected by SWI were significantly greater than 14 lesions detected by T1 weighted imaging, 22 lesions detected by T2 weighted imaging and 86 lesions detected by diffusion weighted imaging. After treatment for 24 hours, the number of CMBs (number: 10 vs. 0), after treatment for 14 days, the incidence of HT [36.36% (28/77) vs. 12.12% (4/33)], MRS (1.78±0.39 vs. 1.51±0.42) and PDW [(12.34±5.29)% vs. (6.79±3.27)%] in the hemorrhagic group were higher than those in non-hemorrhagic group (all P < 0.05). After treatment of 14 days, the incidences of HT [71.43% (15/21) vs. 20.83% (5/24), 25.00% (8/32)], PDW [(14.52±4.11)% vs. (10.78±3.67)%, (11.34±3.89)%] in severe group were higher than those in light group and moderate groups (all P < 0.05), and the rate of good prognosis was significantly lower than those in mild and moderate groups [42.86% (9/21) vs. 70.83% (17/24), 71.88% (23/32), P < 0.05]. The incidence of HT in severe group was also significantly higher than those in the non-hemorrhage group [71.43% (15/21) vs. 11.76% (4/34), P < 0.05]. Conclusion SWI combined with PDW can guide the intravenous thrombolysis very well for patients with ACI, and has relatively high clinical value.

Interventional Ultrasound Assisted Early Local Hemostatic Drug Therapy in Traumatic Intracerebral Hemorrhage

Miniature pig model of combined traumatic brain injury and acute intracranial hypertension with hemorrhagic shock

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

Interventional treatment of hepatic or splenic trauma under the guidance of contrast-enhanced ultrasound:an animal experiment

Focal Injection of Hemostatic Agents under the Guidance of Contrast-Enhanced Ultrasonography in Experimental Splenic Trauma

Hemostatic Agents Injected into Injury Sites under the Guidance of Contrast-Enhanced Ultrasound Control Hepatic Trauma Hemorrhage: an Animal Experiment

Effect of minimally invasive surgery for intracerebral hemorrhage: a single center retrospective analysis

Percutaneous injection of hemostatic agents for severe blunt hepatic trauma: an experimental study

Hemostatic agents injected directly into hepatic injury sites for liver trauma hemorrhage under the guidance of contrast-enhanced ultrasound: an animal experiment.

Minimally invasive hemostasis therapy for hepatic and splenic trauma under the guidance of contrast-enhanced ultrasonography

An Experimental Study of Contrast Enhanced Ultrasound Diagnosis of Cerebral Intraparenchymal Hemorrhage in Dogs

Real-time Ultrasound-Guided External Intracerebral Hemorrhage Drain Placement

1282: Injection Therapy of Hepatic or Splenic Hemorrhagic Trauma Under Contrast-Enhanced Ultrasound Guidance

Establishing an Animal Model of Intracerebral Hemorrhage under the Guidance of Ultrasound.

Combined Haemostatic Percutaneous Injection Therapy for Renal Trauma under Guidance of Contrast-Enhanced Ultrasonography

Clinical effect of neuroendoscopy guided by ultrasound in minimally invasive surgery of hypertensive intracerebral hemorrhage

Effects of injecting heparin into the center of hematoma on perihematoma edema and hematoma volume in pigs with intracerebral hemorrhage

Three-dimensional laser combined with C-arm computed tomography-assisted puncture of intracerebral hemorrhage

Percutaneous injection of hemostatic agents under the guidance of contrast enhanced ultrasonography for stopping hemorrhage from severe splenic rupture

Contrast-Enhanced Sonographic Guidance for Local Injection of A Hemostatic Agent for Management of Blunt Hepatic Hemorrhage: A Canine Study

Magnetic Targeting Nanocarriers Combined with Focusing Ultrasound for Enhanced Intracerebral Hemorrhage Therapy.